ArticleKorean journal of ophthalmology : KJO2026
Long-term Impact of COVID-19-Related Behavioral Changes on Myopia Progression in Children: A Four-Year Cohort Study.
Article in Korean journal of ophthalmology : KJO, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeTo evaluate the effect of behavioral changes during the COVID-19 pandemic on myopia progression in children and to determine whether these changes modified the efficacy of low-concentration atropine.
methodsThis retrospective longitudinal study included children aged 7 to 15 years who underwent annual examinations from 2019 to 2023. A subset of participants completed a behavioral questionnaire in 2021. Annual spherical equivalent measurements from pre-COVID-19 (2019), during the COVID-19 (2020), and post-COVID-19 (2021-2023) periods were analyzed using linear mixed-effects models. Changes in mobile device use and outdoor activity were assessed with repeated measures ANOVA. Subgroup analyses were performed based on the degree of increase in device use and the duration of remote education.
resultsSeventy-seven children (140 eyes) were included in the refractive analysis, of whom 37 (69 eyes) completed the behavioral questionnaire and were included in behavioral analyses. Myopia progression during COVID-19 increased compared with the pre-COVID-19 period. A greater increase in mobile device use was significantly associated with faster progression between 2021 and 2022 (p = 0.005). Longer duration of remote education showed a similar association (p = 0.035). Changes in outdoor activity were not clearly associated with refractive outcomes. Low-dose atropine did not show a meaningful treatment effect in this cohort.
conclusionsMyopia progression accelerated during the pandemic and was strongly associated with increased screen time and prolonged remote education. These behavioral factors had a greater influence on progression than low-dose atropine, underscoring the importance of addressing visual habits in pediatric myopia management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.